ResearcherHarvard UniversityActive in the last 2 years
Anand Mahadevan
Matched on ORCID iD 0000-0003-3555-4217; OpenAlex author ID A5007170568. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 28
2016: 1 paper · 2017: 2 papers · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper
Papers 5
- SBRT for Pancreatic Cancer: A Radiosurgery Society Case-Based Practical Guidelines to Challenging Cases. Co-author DOI 10.1016/j.prro.2024.06.004↗
- Maximizing Tumor Control and Limiting Complications With Stereotactic Body Radiation Therapy for Pancreatic Cancer. Co-author DOI 10.1016/j.ijrobp.2020.11.017↗
- Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide review. Co-author DOI 10.1002/cncr.30856↗
- Regional variation in the treatment of pancreatic adenocarcinoma: Decreasing disparities with multimodality therapy. Co-author DOI 10.1016/j.surg.2017.03.009↗
- A Tale of Two Cities: Reconsidering Adjuvant Radiation in Pancreatic Cancer Care. Co-author DOI 10.1007/s11605-015-2951-8↗
Closest collaborators
The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Karyn A. Goodman · 2 shared papers, 2021–2024 · strength 0.30
- Amol Kumar Narang · 2 shared papers, 2021–2024 · strength 0.30
- Mariam F. Eskander · 3 shared papers, 2016–2017 · strength 0.19
- Paper Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide review. DOI 10.1002/cncr.30856↗
- Paper Regional variation in the treatment of pancreatic adenocarcinoma: Decreasing disparities with multimodality therapy. DOI 10.1016/j.surg.2017.03.009↗
- Paper A Tale of Two Cities: Reconsidering Adjuvant Radiation in Pancreatic Cancer Care. DOI 10.1007/s11605-015-2951-8↗
- Susanna W.L. de Geus · 3 shared papers, 2016–2017 · strength 0.19
- Paper Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide review. DOI 10.1002/cncr.30856↗
- Paper Regional variation in the treatment of pancreatic adenocarcinoma: Decreasing disparities with multimodality therapy. DOI 10.1016/j.surg.2017.03.009↗
- Paper A Tale of Two Cities: Reconsidering Adjuvant Radiation in Pancreatic Cancer Care. DOI 10.1007/s11605-015-2951-8↗
- Jennifer F. Tseng · 3 shared papers, 2016–2017 · strength 0.19
- Paper Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide review. DOI 10.1002/cncr.30856↗
- Paper Regional variation in the treatment of pancreatic adenocarcinoma: Decreasing disparities with multimodality therapy. DOI 10.1016/j.surg.2017.03.009↗
- Paper A Tale of Two Cities: Reconsidering Adjuvant Radiation in Pancreatic Cancer Care. DOI 10.1007/s11605-015-2951-8↗
- William Adrian Hall · 1 shared paper, 2024 · strength 0.18
- Michael David Chuong · 1 shared paper, 2024 · strength 0.18
- Jason Liu · 1 shared paper, 2024 · strength 0.18
- Sarah E. Hoffe · 1 shared paper, 2024 · strength 0.18
- Daniel Tandel Chang · 1 shared paper, 2024 · strength 0.18
- Terence Marques Williams · 1 shared paper, 2024 · strength 0.18
- Christopher H. Crane · 1 shared paper, 2024 · strength 0.18
- Percy P. Lee · 1 shared paper, 2024 · strength 0.18
- Gyulnara G. Kasumova · 2 shared papers, 2017 · strength 0.14
- Mark P. Callery · 2 shared papers, 2016–2017 · strength 0.12
- Tara Sotsky Kent · 2 shared papers, 2016–2017 · strength 0.12
- Dwight Earl Heron · 1 shared paper, 2021 · strength 0.12
- Simon Shek-Man Lo · 1 shared paper, 2021 · strength 0.12
- Manisha Palta · 1 shared paper, 2021 · strength 0.12
- Joseph M. Herman · 1 shared paper, 2021 · strength 0.12
- X. Allen Li · 1 shared paper, 2021 · strength 0.12
- Shalini Moningi · 1 shared paper, 2021 · strength 0.12
- Joseph Douglas Mancias · 1 shared paper, 2017 · strength 0.07
- Rebecca Anne Miksad · 1 shared paper, 2017 · strength 0.07
- Lindsay A. Bliss · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.